UiPath stock is down 34.6% since April when I last covered it after profit guidance was slashed during the first quarter of fiscal 2025 financial results. The change in management and addressing ...

UiPath (NYSE: PATH) is a tiny company compared to Microsoft. The stock of the maker of robotic process automation (RPA) software is only worth $7.2 billion, while the diversified tech titan is worth a ...

Detailed price information for Uipath Inc Cl A (PATH-N) from The Globe and Mail including charting and trades.

Palantir’s revenue accelerated again as its profits soared. UiPath’s growth stalled out as it faced macro and competitive challenges. The pricier stock should be the better buy for the foreseeable ...

In recent weeks, UiPath announced new agentic AI solutions for healthcare revenue cycle management, achieved the AIUC-1 certification for secure enterprise AI agents, and prepared to report quarterly ...

UiPath's share price has risen in recent months despite ongoing losses and slow growth. While market conditions are stable, there is still elevated deal scrutiny and longer sales cycles, particularly ...

UiPath Inc. PATH traded lower Thursday after investors weighed a strong quarter against measured fiscal 2027 guidance. The software company beat Wall Street estimates, but management’s outlook and ...

Shares of UiPath Inc. fell sharply after hours on Wednesday after the business-automation software platform forecast sales for the year ahead that came in below Wall Street’s expectations, citing ...

UiPath’s blended fair value estimate has been trimmed from US$16.19 to US$15.93, a move that sits alongside bullish analyst price targets up to US$18 and recent target cuts from more cautious voices.

UiPath’s latest earnings report exceeded analysts’ expectations. But it significantly reduced its revenue and operating profit guidance for the year. Its CEO also abruptly stepped down. Those headline ...